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USCOM is an ultrasound-based method which has been accepted for noninvasive hemodynamic monitoring in various clinical
conditions (USCOM, Ultrasonic cardiac output monitoring). The present study aimed at comparing the accuracy of the USCOM
device with that of the thermodilution technique in patients with septicemia. We conducted a prospective observational study in
a medical but noncardiological ICU of a university hospital. Septic adult patients (median age 55 years, median SAPS-II-Score
43 points) on mechanical ventilation and catecholamine support were monitored with USCOM and PiCCO (n = 70). Seventy
paired left-sided CO measurements (transaortic access=COUS-A) were obtained. The mean COUS-A were 6.55l/min (±2.19) versus
COPiCCO 6.5l/min (±2.18). The correlation coeﬃcient was r = 0.89. Comparison by Bland-Altman analysis revealed a bias of
−0.36l/min (±0.99l/min) leading to a mean percentage error of 29%. USCOM is a feasible and rapid method to evaluate CO
in septic patients. USCOM does reliably represent CO values as compared to the reference technique based on thermodilution
(PiCCO). It seems to be appropriate in situations where CO measurements are most pertinent to patient management.
1.Introduction
Thermodilution cardiac output measurements have been
routinely performed as part of intensive care practice since
the introduction of the balloon-directed, thermistor-tipped
pulmonary artery catheter in the 1970s [1–3]. Introduced by
Swan and Ganz, the pulmonary artery catheter (PAC) be-
came to be the gold standard for more than two decades [1,
2]. However, arrhythmia, infection, and possible pulmonary
artery disruption have always been concerns related to the
useofaPACandledtoagrowinginterestinthedevelopment
ofnoninvasivehemodynamicmonitoringdevices[4–6].One
less invasive thermodilution-based technique consists of the
pulse-induced cardiac output device (PiCCO) but exclusive-
ly ultrasound-based devices as the USCOM monitor are en-
tirely non-invasive methods for measuring CO [7–13]. Be-
side accuracy and the method-related risks, another crucial
criterion consists of the time required for the determination
of CO [14]. USCOM is a feasible, continuous-wave Doppler-
basedmethodwhichnoninvasivelymeasuresCOinafastand
economical way.
The present study aimed at comparing the accuracy of
the USCOM device with that of the thermodilution tech-
nique (PiCCO) in septic patients.2 Critical Care Research and Practice
2.MaterialsandMethods
Seventy adult, predominantly and mechanically ventilated,
patients were investigated in this observational study. All pa-
tients suﬀered from septic infections and required catechol-
aminesupport.Thestudyprotocolwasapprovedbytheinsti-
tutionalethicscommittee.Astheprotocolwastheconsidered
part of the routine practice, informed consent was waived.
All patients were measured by PiCCO and USCOM
(COUS−A left-sided aortal access n = 70). With the assistance
ofanurse,COmeasurements(CO USCOM,CO PiCCO)werecar -
ried out simultaneously. All measurements were undertaken
duringpatientswerehemodynamicallystablethroughoutthe
time of CO measurements. The PiCCO device was recali-
brated immediately prior to any measurements by USCOM.
To exclude an interindividual observer variability, all CO
measurements by USCOM and PiCCO were undertaken by
the same investigator.
2.1. USCOM. The USCOM device (USCOM Ltd., Sydney,
Australia) is a non-invasive bedside method to evaluate car-
diac output basing on continuous-wave Doppler ultrasound.
After starting the USCOM device, the left-sided transaortic
(COUS-A) or right-sided transpulmonary access has to be
chosen before the patients data like height, weight, and gen-
der are typed in. The ﬂow proﬁle is obtained by commonly
using a 2.2MHz transducer placed on the chest in either the
left parasternal position to measure transpulmonary blood
ﬂow (right-sided access, 3rd to 5th parasternal intercostal
space) or the suprasternal position to measure transaortic
blood ﬂow (left-sided access, suprasternal notch). The oper-
ator registries a Doppler ﬂow curve with maximal blood ﬂow
which is characterized by a sharp, well-deﬁned waveform
with the clearest audible sound. The ﬂow proﬁle is displayed
as a time velocity curve at the monitor (VTI: velocity time
integral). Once the optimal ﬂow proﬁle is obtained, the trace
is frozen. The USCOM device calculates CO by the product
of stroke volume (SV) and heart rate (HR) where the SV is
the product of the velocity time integral (VTI) and the cross-
sectional area of the chosen valve (CSA). The chosen valve
cross-sectional area is given by the USCOM internal algo-
rithm based on the formerly typed in patients data (height
and gender) [15, 16].
2.2. PiCCO. Continuous cardiac output using pulse contour
analysis was measured by the PiCCO plus system (Pulsion
Medical Systems, Munich, Germany). Cardiac output was
measured discontinuously by thermodilution using a trip-
licate injection of 15mL ice-cold 0.9% saline administered
through a temperature detecting inline sensor central vein
catheter [17]. A femoral or brachial artery catheter (4-F
aortic catheter with an integrated thermistor) registers the
time until the bolus attains and identiﬁes the alteration of
temperature [18].
2.3. Statistical Analysis. The Bland-Altman Plot was used to
estimate the bias and limits of agreement between meas-
urements by the two methods [19]. According to the recom-
mendations by L. A. H. Critchley and J. A. H. Critchley, we
quoted the mean CO (µ), the bias, the limits of agreement
(95% CI), and the percentage error (±2SD/µ)[ 20]. Bland-
Altman plots and correlation curves were performed using
GraphPad for Windows (Version 5.01, GraphPad Software,
San Diego, California, USA).
For statistical calculations (Pearsons’ correlation coeﬃ-
cient) SPSS for Windows was used (Version 15.0, SPSS Insti-
tute, Chicago, Ill, USA).
3. Results
3.1. Patient Characteristics. Seventy mechanically ventilated
patients with a catecholamine support (median norepineph-
rine 0.55mg/h c.i., range 0.1–3.0) at a median age of 45 years
and a median SAPS Score of 43 points were enrolled. The
majorities of the patients suﬀered from hematological (n =
38) or hepatological diseases (n = 16). In 9 cases, patients
had received prior chemotherapy- for solid tumors (n = 9),
and 7 patients suﬀered from other diseases. All patients ful-
ﬁlled the criteria for sepsis. In most cases sepsis was related
to chemotherapy-induced neutropenia. Detailed patients’
characteristics are given in Table 1.
3.2. Detection Ability: USCOM. In total, 70 left-sided, trans-
aortic CO measures from 70 subjects were acquired. High-
quality, left-sided transaortic doppler signals could not be
obtained in two patients due to anatomic variability (short
neck and tracheostoma). The detection ability rate was
COUS-A 98.4%.
3.3. USCOM versus PiCCO
3.3.1. Transaortic Analysis: COUS-A. The CO values of seven-
ty patients were measured by PiCCO and left-sided transaor-
tic USCOM (126 paired measurements).
The median CO was 6.5l/min (±2.18) for PiCCO device
and 6.55l/min (±2.19) for the transaortic measurements
with USCOM. The Pearsons’ correlation coeﬃcient was r =
0.89 (P<0.01) (Figure 1).
The bias, using the Bland-Altman analysis, was
−0.36l/min (±0.99l/min) with 95% limits of agreement
from −2.34 to 1.62 (Figure 2). The mean percentage error
according to Critchley L. A. H. and J. A. H. Critchley
amounts to 29%.
3.3.2. Time Requirement: tCOUS-A versus tCOPiCCO. The time
requirements for each single method of CO measurements
were recorded (starting the device: ﬁrst admissible result) on
the following preconditions.
PiCCO artery and central venous line were already in
situ. The PiCCO device was recalibrated immediately prior
to measurements.
Mean measurement time of PiCCO-(tCOPiCCO) was 8.46
minutes (min) (±2.15; min/max 4.0/20.0min) and of trans-
aortic USCOM (tCOUS-A) analysis 3.69min (±1.59; min/max
1.0/10.0min).Critical Care Research and Practice 3
Table 1: Patient characteristics.
n = 70 Value/median range Standard deviation
(+/−SD)
Baseline characteristics
Age 45 years 23–78
Gender 45m/25 f
ICU characteristics
SAPS II score 43 23–60 7.14
BP (systolic) 124mmHg 94–170 19.78
BP (diastolic) 58mmHg 37–70 21.62
HR 97bpm 53–142 20.0
CVP 10mbar 3–17 5.02
Norepinephrine 0.5mg/h 0.1–3.0 2.01
Mechanically ventilated 70
ﬁO2 0.5 0.3–1.0
Hepatological disease 16
Liver cirrhosis 12
SBP 5
Hepatitis 1
GI bleeding 3
Pneumonia 2
HCC 1
Acute liver failure 4
Liver transplantation 2
Haematological disease 38
Acute leukaemia 12
SCT 6
Chronic leukaemia 4
Lymphoma 11
Myeloma 5
Solid tumors 9
GI cancer 5
Breast cancer 3
Lung cancer 1
Other 7
Abbreviations: BP: blood pressure, HR: heart rate, CVP: central vein pres-
sure, SBP: spontaneous bacterial peritonitis, HCC: hepatocellular carci-
noma, SCT: stem cell transplantation, and GI: gastrointestinal.
4. Discussion
This study aimed to compare the accuracy of CO measure-
ments between the noninvasive continuous-wave Doppler-
based monitoring system USCOM and a thermodilution-
based technique (PiCCO).
USCOM is a noninvasive cardiac output monitor based
on the transthoracic measurement of Doppler ﬂow velocity
over the aortic and pulmonary outﬂow tract. It is easy to
operate,andCOisdisplayed“beatbybeat”.Followingashort
booting time, the device can be used immediately. Moreover,
the technique is reported to be easily learned after a short
learning period by nonphysicians [21, 22].
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Figure 1:CorrelationofCOmeasurementsbyUSCOMandPiCCO
(median CO USCOM 6.55L/min ±2.19, median CO PiCCO
6.5L/min ±2.18; r = 0.89) (increased size of points which are
multiples).
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Figure 2: Bland-Altmann plot of left-sided, aortal CO measure-
ments by USCOM versus PiCCO. The mean bias was −0.36L/min
± 0.99 with 95% limits of agreement from −2.34 to 1.62. The
percentage error according to Critchley and Critchley was 29%.
In contrast to previously reported trials which investi-
gated USCOM in predominantly cardiac surgical patients’
collectives, we analyzed patients with sepsis. A former pilot
study indicated a comparable accuracy of USCOM and the
PiCCO device in a similar patients subset [23]. According
to these data, the present study indicated also an acceptable
agreement between the USCOM CO measurements and
those determined by a thermodilution-based method.
For analyzing the accuracy, the Bland-Altman method
was used because it measures the extent of deviation from
the line of complete agreement (no bias) between the meth-
ods. This is diﬀerent from the correlation coeﬃcient which
measures how close to a straight line the pairs of measure-
ments lie, but that line need not to be the one of complete
agreement. Moreover, in addition to reporting the mean
cardiac output (µ), the bias, and the limits of agreement
(95%CI), we quoted the percentage error as recommended
by, L. A. H. Critchley and J. A. H. Critchley [20].
Analysing the accuracy of COUS and COPiCCO, the Pear-
sons’ correlation coeﬃcient was 0.89 which seems compara-
ble to that reported in the study of Knobloch and coworkers.4 Critical Care Research and Practice
They investigated 36 patients by PAC and USCOM and
obtained a comparable correlation coeﬃcient of r = 0.87
(P<0.01) [12]. By analyzing our data with the Bland-
Altman method, the mean percentage error according to
L. A. H. Critchley and J. A. H. Critchley was 29% for the
transaortic access. Since the accepted threshold is <30% one
can conclude that transaortic CO measurements by USCOM
do reliably reﬂect the measurements by PiCCO.
In contrast to these data, an inferior accuracy for
USCOM was reported by other authors who found that CO
measurements by USCOM do not reliably represent absolute
values as compared to pulmonary artery catheter thermod-
ilution technique [16, 24]. Possible explanations for such
incoherent ﬁndings are as follows.
(1) Partsofreportedexaminationsweredoneduringcar-
diacsurgerybyplacingtheprobedirectlyontheright
ventricular outﬂow tract. Patients in our study, for
instance, were ventilated mechanically which con-
tributes to diﬃculties in CO measurements by an
ultrasound-based device.
(2) In cases of relatively high cardiac output, USCOM
tends to underestimate the real CO value when it is
relatively high [9–11]. On the contrary, such a differ-
ence does not appear in Su et al.’s research [10, 11].
Theyinvestigatedpatientswithlivercirrhosisbecause
of their unique hyperdynamic status with high CO
values ranging up to 13.6L/min. They found that
even at high CO values, USCOM still reliably mea-
sures CO [10, 11].
(3) The accuracy of the USCOM depends on obtaining
accurate VTI and valve diameter measurements. An
accurate VTI measurement requires a good ﬂow sig-
nal. An inadequate beam alignment with the blood
ﬂowdirectionwillleadtosuboptimal Dopplersignal.
(4) The cross-sectional area of the chosen valve contrib-
utestotheestimatedCO(CO=HR ×SV;SV=VTI ×
CSA). The valve area is given by the height-based
algorithm built into the device. Knirsch et al. studied
twenty-four pediatric patients with congenital heart
disease without shunt undergoing cardiac catheteri-
zation under general anesthesia [16].Interpreting the
moderate accuracy of USCOM in their study, it has
to be considered that the USCOM algorithm which
determinates the valve cross-sectional area based on
the data of healthy volunteers [15]. Despite the op-
portunity to correct the valve cross-sectional area
manually in cases of known cardiac valve anomalies
after exact evaluation by transthoracic or transeso-
phageal echocardiography, the ﬁrst examination by
USCOM can be misleadingly too low or too high.
(5) ThePiCCOdevicemaybenotasaccurateasreference
technique in this setting (septicemic patients). Any
bias and limits of agreement observed in this study
could therefore be explained by the inaccuracy of the
PiCCO system. The accepted clinical standard is still
the intermittent thermodilution technique which in
has its own inherent variability [25–27].
Early goal-directed therapy (EGDT) has become regard-
ed as the standard of care for the management of patients
with severe sepsis and septic shock [14, 28, 29]. However,
it is critical to discuss that the concept of EGDT is still an
issue of controversy [30]. Nevertheless, USCOM is attractive
in many ways. It is easy to use, and as an ultrasound tech-
niqueissafesoitcanbeusedrepeatedlytomeasurethetrend
over time. It avoids the problems of an esophageal probe
and is tolerated by awaken patients. Moreover, by using the
USCOM device the physician will obtain a result in an un-
beatable period of time. The role of USCOM is evolving
but USCOM is limited to CO measurements and does not
provide variables as pressure measurements or ScvO2.T h u s ,
USCOM does not replace invasive methods as PiCCO or
P A C .B u tU S C O Ms e e m st ob ea p p r o p r i a t ei ns i t u a t i o n s
where CO measurement is most pertinent to patient man-
agement.
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